If we end up with a hierarchy that says all rich White people get Pfizer, and all poor Black people get J&J, that would be a problem.

Helene D. Gayle, president and chief executive of the Chicago Community Trust, one of the largest community foundations in the country, commenting to The Washington Post for its story this week, “Johnson & Johnson Vaccine Deepens Concerns Over Racial And Geographic Inequities.”